Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Achieving adequate oral immunosuppression in a renal transplant patient who develops short bowel syndrome provides a significant challenge. We report a case where oral tacrolimus has been used to provide immunosuppression in an established renal transplant patient who developed short bowel syndrome secondary to mesenteric infarction. After reviewing the literature, we conclude that tacrolimus can be used as first-line immunosuppression in patients with short bowel syndrome.

Original publication

DOI

10.1007/s00147-003-0606-2

Type

Journal article

Journal

Transpl Int

Publication Date

01/2004

Volume

17

Pages

44 - 45

Keywords

Administration, Oral, Adult, Female, Humans, Immunosuppressive Agents, Infarction, Kidney Transplantation, Short Bowel Syndrome, Splanchnic Circulation, Tacrolimus